Please assess the completion status of the following clinical trial:

Trial Title: The CAPTAIN Trial: Cerebrolysin Asian Pacific Trial in Acute Brain Injury and Neurorecovery

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Clinical diagnosis of TBI and a GCS 7-12~* Only isolated TBI~* CT~* Pre-Trauma Karnofsky-Index = 100~* Age 18-60 years~* Male and female patients~* Time to needle for study medication within 6 hours after injury~* Patient is not pregnant or lactating during the trial and is not of childbearing potential~* Patient was able to speak, read and write in a pre-defined study language before the accident.~* Reasonable expectation of completion of outcome measures at follow-up~* Written informed consent~Exclusion Criteria:~* Evidence of pre-existing major health problems~* Any neurological or non-neurological condition independent from TBI that might influence the functional outcome or other efficacy outcome measures~* Injury of writing hand influencing cognitive or other outcome measures~* Clear clinical signs of intoxication influencing the evaluation~* Major drug dependency including alcohol~* Chronic treatment with steroids, Ca2+-channel blockers or major anticoagulants~* Penetrating high-velocity missile head trauma~* Stab wound trauma into the brain~* Patients with spinal cord injury

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 60 Years
- Healthy Volunteers: f

Study Arms:
- 0.9% NaCl, saline (Type: PLACEBO_COMPARATOR): None
- Cerebrolysin (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).